Skip to main content

Advertisement

Log in

Neuroactive steroids, negative affect, and nicotine dependence severity in male smokers

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Nicotine administration alters neuroactive steroids in rodent models, and serum levels of the neuroactive steroid DHEAS (dehydroepiandrosterone sulfate) appear to be higher in smokers. These molecules may be relevant to tobacco addiction and affective symptoms.

Objectives

This study aims to investigate DHEAS, allopregnanolone, pregnenolone, and other steroids in male smokers to determine potential associations with nicotine dependence severity and negative affect.

Materials and methods

Allopregnanolone and pregnenolone serum levels were determined by gas chromatography/mass spectrometry, while DHEAS and other steroid levels were determined by radioimmunoassay in 28 male smokers. Correlational analyses were performed to determine potential associations with rating measures, including the Fagerstrom Test for Nicotine Dependence (FTND), the addiction subscale of the Ikard Smoking Motivation Questionnaire (ISMQ), the craving item on the Reasons to Smoke (RTS) Questionnaire, and the negative affect and craving subscales of the Shiffman–Jarvik Withdrawal Questionnaire.

Results

DHEAS levels were inversely correlated with the negative affect subscale of the Shiffman–Jarvik Withdrawal Questionnaire (r=−0.60, p=0.002) and the RTS craving item (r=−0.43, p=0.03), and tended to be inversely correlated with the FTND scores (r=−0.38, p=0.067) and the ISMQ addiction subscale (r=−0.38, p=0.059), adjusting for age. Allopregnanolone levels were positively correlated with cotinine levels (r=0.57, p=0.006); pregnenolone levels tended to be positively correlated with cotinine levels (r=0.40, p=0.066).

Conclusions

DHEAS levels were inversely correlated with negative affect and craving measures, and may predict nicotine dependence severity. Allopregnanolone levels were positively correlated with cotinine levels, suggesting that this neuroactive steroid may be upregulated in smokers. Neuroactive steroids may represent novel smoking cessation agents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Adan A, Prat G, Sanchez-Turet M (2004) Effects of nicotine dependence on diurnal variations of subjective activation and mood. Addiction 99:1599–1607

    Article  PubMed  Google Scholar 

  • al’Absi M, Amunrud T, Wittmers LE (2002) Psychophysiological effects of nicotine abstinence and behavioral challenges in habitual smokers. Pharmacol Biochem Behav 72:707–716

    Article  PubMed  CAS  Google Scholar 

  • al’Absi M, Wittmers LE, Erickson J, Hatsukami D, Crouse B (2003) Attenuated adrenocortical and blood pressure responses to psychological stress in ad libitum and abstinent smokers. Pharmacol Biochem Behav 74:401–410

    Article  PubMed  CAS  Google Scholar 

  • al’Absi M, Hatsukami D, Davis GL, Wittmers LE (2004) Prospective examination of effects of smoking abstinence on cortisol and withdrawal symptoms as predictors of early smoking relapse. Drug Alcohol Depend 73:267–278

    Article  PubMed  CAS  Google Scholar 

  • Anda RF, Williamson DF, Escobedo LG, Mast EE, Giovino GA, Remington PL (1990) Depression and the dynamics of smoking. A national perspective. JAMA 264:1541–1545

    Article  PubMed  CAS  Google Scholar 

  • Barbaccia ML, Affricano D, Purdy RH, Maciocco E, Spiga F, Biggio G (2001) Clozapine, but not haloperidol, increases brain concentrations of neuroactive steroids in the rat. Neuropsychopharmacology 25:489–497

    Article  PubMed  CAS  Google Scholar 

  • Barbaccia ML, Concas A, Serra M, Biggio G (1998) Stress and neurosteroids in adult and aged rats. Exp Gerontol 33:697–712

    Article  PubMed  CAS  Google Scholar 

  • Barbaccia ML, Roscetti G, Trabucchi M, Mostallino MC, Concas A, Purdy RH, Biggio G (1996) Time-dependent changes in rat brain neuroactive steroid concentrations and GABAA receptor function after acute stress. Neuroendocrinology 63:166–172

    Article  PubMed  CAS  Google Scholar 

  • Baron JA, Comi RJ, Cryns V, Brinck-Johnsen T, Mercer NG (1995) The effect of cigarette smoking on adrenal cortical hormones. J Pharmacol Exp Ther 272:151–155

    PubMed  CAS  Google Scholar 

  • Barrett-Connor E, Khaw KT, Yen SS (1986) A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med 315:1519–1524

    PubMed  CAS  Google Scholar 

  • Bernardi F, Lanzone A, Cento RM, Spada RS, Pezzani I, Genazzani AD, Luisi S, Luisi M, Petraglia F, Genazzani AR (2000) Allopregnanolone and dehydroepiandrosterone response to corticotropin-releasing factor in patients suffering from Alzheimer’s disease and vascular dementia. Eur J Endocrinol 142:466–471

    Article  PubMed  CAS  Google Scholar 

  • Berr C, Lafont S, Debuire B, Dartigues JF, Baulieu EE (1996) Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a French community-based study. Proc Natl Acad Sci USA 93:13410–13415

    Article  PubMed  CAS  Google Scholar 

  • Bjornerem A, Straume B, Midtby M, Fonnebo V, Sundsfjord J, Svartberg J, Acharya G, Oian P, Berntsen GK (2004) Endogenous sex hormones in relation to age, sex, lifestyle factors, and chronic diseases in a general population: the Tromso Study. J Clin Endocrinol Metab 89:6039–6047

    Article  PubMed  CAS  Google Scholar 

  • Breslau N, Kilbey MM, Andreski P (1993) Nicotine dependence and major depression. New evidence from a prospective investigation. Arch Gen Psychiatry 50:31–35

    PubMed  CAS  Google Scholar 

  • Brot MD, Akwa Y, Purdy RH, Koob GF, Britton KT (1997) The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABA(A) receptors. Eur J Pharmacol 325:1–7

    Article  PubMed  CAS  Google Scholar 

  • Caggiula AR, Donny EC, Epstein LH, Sved AF, Knopf S, Rose C, McAllister CG, Antelman SM, Perkins KA (1998) The role of corticosteroids in nicotine’s physiological and behavioral effects. Psychoneuroendocrinology 23:143–159

    Article  PubMed  CAS  Google Scholar 

  • Compagnone NA, Mellon SH (1998) Dehydroepiandrosterone: a potential signalling molecule for neocortical organization during development. Proc Natl Acad Sci USA 95:4678–4683

    Article  PubMed  CAS  Google Scholar 

  • Covey LS, Glassman AH, Stetner F (1997) Major depression following smoking cessation. Am J Psychiatry 154:263–265

    PubMed  CAS  Google Scholar 

  • Crawley JN, Glowa JR, Majewska MD, Paul SM (1986) Anxiolytic activity of an endogenous adrenal steroid. Brain Res 398:382–385

    Article  PubMed  CAS  Google Scholar 

  • Debonnel G, Bergeron R, de Montigny C (1996) Potentiation by dehydroepiandrosterone of the neuronal response to N-methyl-d-aspartate in the CA3 region of the rat dorsal hippocampus: an effect mediated via sigma receptors. J Endocrinol 150:S33–S42

    Article  PubMed  CAS  Google Scholar 

  • Dong E, Matsumoto K, Uzunova V, Sugaya I, Takahata H, Nomura H, Watanabe H, Costa E, Guidotti A (2001) Brain 5alpha-dihydroprogesterone and allopregnanolone synthesis in a mouse model of protracted social isolation. Proc Natl Acad Sci USA 98:2849–2854

    Article  PubMed  CAS  Google Scholar 

  • Fagerstrom KO (1978) Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav 3:235–241

    Article  PubMed  CAS  Google Scholar 

  • Fagerstrom KO, Schneider NG (1989) Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J Behav Med 12:159–182

    Article  PubMed  CAS  Google Scholar 

  • Feldman HA, Johannes CB, McKinlay JB, Longcope C (1998) Low dehydroepiandrosterone sulfate and heart disease in middle-aged men: cross-sectional results from the Massachusetts Male Aging Study. Ann Epidemiol 8:217–228

    Article  PubMed  CAS  Google Scholar 

  • Field AE, Colditz GA, Willett WC, Longcope C, McKinlay JB (1994) The relation of smoking, age, relative weight, and dietary intake to serum adrenal steroids, sex hormones, and sex hormone-binding globulin in middle-aged men. J Clin Endocrinol Metab 79:1310–1316

    Article  PubMed  CAS  Google Scholar 

  • Frederick SL, Reus VI, Ginsberg D, Hall SM, Munoz RF, Ellman G (1998) Cortisol and response to dexamethasone as predictors of withdrawal distress and abstinence success in smokers. Biol Psychiatry 43:525–530

    Article  PubMed  CAS  Google Scholar 

  • Genazzani AR, Petraglia F, Bernardi F, Casarosa E, Salvestroni C, Tonetti A, Nappi RE, Luisi S, Palumbo M, Purdy RH, Luisi M (1998) Circulating levels of allopregnanolone in humans: gender, age, and endocrine influences. J Clin Endocrinol Metab 83:2099–2103

    Article  PubMed  CAS  Google Scholar 

  • Genazzani AD, Stomati M, Bernardi F, Pieri M, Rovati L, Genazzani AR (2003) Long-term low-dose dehydroepiandrosterone oral supplementation in early and late postmenopausal women modulates endocrine parameters and synthesis of neuroactive steroids. Fertil Steril 80:1495–1501

    Article  PubMed  Google Scholar 

  • Gilbert DG, McClernon FJ, Rabinovich NE, Dibb WD, Plath LC, Hiyane S, Jensen RA, Meliska CJ, Estes SL, Gehlbach BA (1999) EEG, physiology, and task-related mood fail to resolve across 31 days of smoking abstinence: relations to depressive traits, nicotine exposure, and dependence. Exp Clin Psychopharmacol 7:427–443

    Article  PubMed  CAS  Google Scholar 

  • Girdler SS, Straneva PA, Light KC, Pedersen CA, Morrow AL (2001) Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder. Biol Psychiatry 49:788–797

    Article  PubMed  CAS  Google Scholar 

  • Glassman AH, Covey LS, Stetner F, Rivelli S (2001) Smoking cessation and the course of major depression: a follow-up study. Lancet 357:1929–1932

    Article  PubMed  CAS  Google Scholar 

  • Glassman AH, Helzer JE, Covey LS, Cottler LB, Stetner F, Tipp JE, Johnson J (1990) Smoking, smoking cessation, and major depression. JAMA 264:1546–1549

    Article  PubMed  CAS  Google Scholar 

  • Gossain VV, Sherma NK, Srivastava L, Michelakis AM, Rovner DR (1986) Hormonal effects of smoking—II: effects on plasma cortisol, growth hormone, and prolactin. Am J Med Sci 291:325–327

    Article  PubMed  CAS  Google Scholar 

  • Hautanen A, Manttari M, Kupari M, Sarna S, Manninen V, Frick MH, Adlercreutz H (1993) Cigarette smoking is associated with elevated adrenal androgen response to adrenocorticotropin. J Steroid Biochem Mol Biol 46:245–251

    Article  PubMed  CAS  Google Scholar 

  • Hughes JR, Arana G, Amori G, Stewart F, Workman R (1988) Effect of tobacco withdrawal on the dexamethasone suppression test. Biol Psychiatry 23:96–98

    Article  PubMed  CAS  Google Scholar 

  • Ikard FF, Green DE, Horn D (1969) A scale to differentiate between types of smoking as related to the management of affect. Int J Addict 4:649–659

    Google Scholar 

  • Imamura M, Prasad C (1998) Modulation of GABA-gated chloride ion influx in the brain by dehydroepiandrosterone and its metabolites. Biochem Biophys Res Commun 243:771–775

    Article  PubMed  CAS  Google Scholar 

  • Irwin RP, Lin SZ, Rogawski MA, Purdy RH, Paul SM (1994) Steroid potentiation and inhibition of N-methyl-d-aspartate receptor-mediated intracellular Ca++ responses: structure–activity studies. J Pharmacol Exp Ther 271:677–682

    PubMed  CAS  Google Scholar 

  • Jacob P, 3rd, Wilson M, Benowitz NL (1981) Improved gas chromatographic method for the determination of nicotine and cotinine in biologic fluids. J Chromatogr 222:61–70

    Article  PubMed  CAS  Google Scholar 

  • Jarvis MJ, Primatesta P, Erens B, Feyerabend C, Bryant A (2003) Measuring nicotine intake in population surveys: comparability of saliva cotinine and plasma cotinine estimates. Nicotine Tob Res 5:349–355

    Article  PubMed  CAS  Google Scholar 

  • Kassel JD, Stroud LR, Paronis CA (2003) Smoking, stress, and negative affect: correlation, causation, and context across stages of smoking. Psychol Bull 129:270–304

    Article  PubMed  Google Scholar 

  • Kendler KS, Neale MC, MacLean CJ, Heath AC, Eaves LJ, Kessler RC (1993) Smoking and major depression. A causal analysis. Arch Gen Psychiatry 50:36–43

    PubMed  CAS  Google Scholar 

  • Khaw KT, Tazuke S, Barrett-Connor E (1988) Cigarette smoking and levels of adrenal androgens in postmenopausal women. N Engl J Med 318:1705–1709

    PubMed  CAS  Google Scholar 

  • Laughlin GA, Barrett-Connor E (2000) Sexual dimorphism in the influence of advanced aging on adrenal hormone levels: the Rancho Bernardo Study. J Clin Endocrinol Metab 85:3561–3568

    Article  PubMed  CAS  Google Scholar 

  • Law MR, Cheng R, Hackshaw AK, Allaway S, Hale AK (1997) Cigarette smoking, sex hormones and bone density in women. Eur J Epidemiol 13:553–558

    Article  PubMed  CAS  Google Scholar 

  • Majewska MD, Harrison NL, Schwartz RD, Barker JL, Paul SM (1986) Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232:1004–1007

    Article  PubMed  CAS  Google Scholar 

  • Majewska MD, Mienville JM, Vicini S (1988) Neurosteroid pregnenolone sulfate antagonizes electrophysiological responses to GABA in neurons. Neurosci Lett 90:279–284

    Article  PubMed  CAS  Google Scholar 

  • Marx CE, Duncan GE, Gilmore JH, Lieberman JA, Morrow AL (2000) Olanzapine increases allopregnanolone in the rat cerebral cortex. Biol Psychiatry 47:1000–1004

    Article  PubMed  CAS  Google Scholar 

  • Marx CE, VanDoren MJ, Duncan GE, Lieberman JA, Morrow AL (2003) Olanzapine and clozapine increase the GABAergic neuroactive steroid allopregnanolone in rodents. Neuropsychopharmacology 28:1–13

    Article  PubMed  CAS  Google Scholar 

  • Matta SG, Fu Y, Valentine JD, Sharp BM (1998) Response of the hypothalamo–pituitary–adrenal axis to nicotine. Psychoneuroendocrinology 23:103–113

    Article  PubMed  CAS  Google Scholar 

  • Meliska CJ, Stunkard ME, Gilbert DG, Jensen RA, Martinko JM (1995) Immune function in cigarette smokers who quit smoking for 31 days. J Allergy Clin Immunol 95:901–910

    Article  PubMed  CAS  Google Scholar 

  • Morrow AL, Devaud LL, Purdy RH, Paul SM (1995) Neuroactive steroid modulators of the stress response. Ann NY Acad Sci 771:257–272

    Article  PubMed  CAS  Google Scholar 

  • Morrow AL, Pace JR, Purdy RH, Paul SM (1990) Characterization of steroid interactions with gamma-aminobutyric acid receptor-gated chloride ion channels: evidence for multiple steroid recognition sites. Mol Pharmacol 37:263–270

    PubMed  CAS  Google Scholar 

  • Morrow AL, Suzdak PD, Paul SM (1987) Steroid hormone metabolites potentiate GABA receptor-mediated chloride ion flux with nanomolar potency. Eur J Pharmacol 142:483–485

    Article  PubMed  CAS  Google Scholar 

  • Oncken C, Prestwood K, Cooney JL, Unson C, Fall P, Kulldorff M, Raisz LG (2002) Effects of smoking cessation or reduction on hormone profiles and bone turnover in postmenopausal women. Nicotine Tob Res 4:451–458

    Article  PubMed  CAS  Google Scholar 

  • Paperwalla KN, Levin TT, Weiner J, Saravay SM (2004) Smoking and depression. Med Clin North Am 88:1483–1494, x–xi

    Article  PubMed  Google Scholar 

  • Park-Chung M, Malayev A, Purdy RH, Gibbs TT, Farb DH (1999) Sulfated and unsulfated steroids modulate gamma-aminobutyric acid A receptor function through distinct sites. Brain Res 830:72–87

    Article  PubMed  CAS  Google Scholar 

  • Parker CR, Jr. (1999) Dehydroepiandrosterone and dehydroepiandrosterone sulfate production in the human adrenal during development and aging. Steroids 64:640–647

    Article  PubMed  CAS  Google Scholar 

  • Paul SM, Purdy RH (1992) Neuroactive steroids. FASEB J 6:2311–2322

    PubMed  CAS  Google Scholar 

  • Pearson Murphy BE, Allison CM (2000) Determination of progesterone and some of its neuroactive ring A-reduced metabolites in human serum. J Steroid Biochem Mol Biol 74:137–142

    Article  PubMed  CAS  Google Scholar 

  • Pickworth WB, Baumann MH, Fant RV, Rothman RB, Henningfield JE (1996) Endocrine responses during acute nicotine withdrawal. Pharmacol Biochem Behav 55:433–437

    Article  PubMed  CAS  Google Scholar 

  • Pickworth WB, Fant RV (1998) Endocrine effects of nicotine administration, tobacco and other drug withdrawal in humans. Psychoneuroendocrinology 23:131–141

    Google Scholar 

  • Pinna G, Dong E, Matsumoto K, Costa E, Guidotti A (2003) In socially isolated mice, the reversal of brain allopregnanolone down-regulation mediates the anti-aggressive action of fluoxetine. PNAS 100:2035–2040

    Article  PubMed  CAS  Google Scholar 

  • Pomerleau CS, Brouwer RJ, Pomerleau OF (2001) Emergence of depression during early abstinence in depressed and non-depressed women smokers. J Addict Dis 20:73–80

    Article  PubMed  CAS  Google Scholar 

  • Porcu P, Sogliano C, Cinus M, Purdy RH, Biggio G, Concas A (2003) Nicotine-induced changes in cerebrocortical neuroactive steroids and plasma corticosterone concentrations in the rat. Pharmacol Biochem Behav 74:683–690

    Article  PubMed  CAS  Google Scholar 

  • Puddey IB, Vandongen R, L.J. B, English D (1984) Haemodynamic and neuroendocrine consequences of stopping smoking—a controlled study. Clin Exp Pharmacol Physiol 11:423–426

    Article  PubMed  CAS  Google Scholar 

  • Purdy RH, Morrow AL, Moore PH, Jr., Paul SM (1991) Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat brain. Proc Natl Acad Sci USA 88:4553–4557

    Article  PubMed  CAS  Google Scholar 

  • Quattrocki E, Baird A, Yurgelun-Todd D (2000) Biological aspects of the link between smoking and depression. Harv Rev Psychiatry 8:99–110

    Article  PubMed  CAS  Google Scholar 

  • Rasmusson AM, Vasek J, Lipschitz DS, Vojvoda D, Mustone ME, Shi Q, Gudmundsen G, Morgan CA, Wolfe J, Charney DS (2004) An increased capacity for adrenal DHEA release is associated with decreased avoidance and negative mood symptoms in women with PTSD. Neuropsychopharmacology 29:1546–1557

    Article  PubMed  CAS  Google Scholar 

  • Rose JE, Behm FM, Westman EC, Bates JE (2003) Mecamylamine acutely increases human intravenous nicotine self-administration. Pharmacol Biochem Behav 76:307–313

    Article  PubMed  CAS  Google Scholar 

  • Rosecrans JA, Karin LD (1998) Effects of nicotine on the hypothalamic–pituitary–axis (HPA) and immune function: introduction to the Sixth Nicotine Round Table Satellite, American Society of Addiction Medicine Nicotine Dependence Meeting, November 15, 1997. Psychoneuroendocrinology 23:95–102

    Article  PubMed  CAS  Google Scholar 

  • Rupprecht R, Holsboer F (1999) Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci 22:410–416

    Article  PubMed  CAS  Google Scholar 

  • Salvini S, Stampfer MJ, Barbieri RL, Hennekens CH (1992) Effects of age, smoking and vitamins on plasma DHEAS levels: a cross-sectional study in men. J Clin Endocrinol Metab 74:139–143

    Article  PubMed  CAS  Google Scholar 

  • Schmidt PJ, Daly RC, Bloch M, Smith MJ, Danaceau MA, St Clair LS, Murphy JH, Haq N, Rubinow DR (2005) Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression. Arch Gen Psychiatry 62:154–162

    Article  PubMed  CAS  Google Scholar 

  • Shiffman SM, Jarvik ME (1976) Smoking withdrawal symptoms in two weeks of abstinence. Psychopharmacology (Berl) 50:35–39

    Article  CAS  Google Scholar 

  • Shiffman S, Paty JA, Gnys M, Kassel JA, Hickcox M (1996) First lapses to smoking: within-subjects analysis of real-time reports. J Consult Clin Psychol 64:366–379

    Article  PubMed  CAS  Google Scholar 

  • Shin HS, Kim JG, Shin YJ, Jee SH (2002) Sensitive and simple method for the determination of nicotine and cotinine in human urine, plasma and saliva by gas chromatography–mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 769:177–183

    Article  PubMed  CAS  Google Scholar 

  • Sinha R (2005) Stress and drug abuse. In: Steckler T, Kalin N, Reul J (eds) Handbook of stress and the brain. Elsevier Science, Amsterdam, pp 333–356

    Chapter  Google Scholar 

  • Strous RD, Maayan R, Lapidus R, Stryjer R, Lustig M, Kotler M, Weizman A (2003) Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia. Arch Gen Psychiatry 60:133–141

    Article  PubMed  CAS  Google Scholar 

  • Tannenbaum C, Barrett-Connor E, Laughlin GA, Platt RW (2004) A longitudinal study of dehydroepiandrosterone sulphate (DHEAS) change in older men and women: the Rancho Bernardo Study. Eur J Endocrinol 151:717–725

    Article  PubMed  CAS  Google Scholar 

  • Tziomalos K, Charsoulis F (2004) Endocrine effects of tobacco smoking. Clin Endocrinol (Oxf) 61:664–674

    Article  Google Scholar 

  • Uzunova V, Sheline Y, Davis JM, Rasmusson A, Uzunov DP, Costa E, Guidotti A (1998) Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci USA 95:3239–3244

    Article  PubMed  CAS  Google Scholar 

  • Vallee M, Rivera JD, Koob GF, Purdy RH, Fitzgerald RL (2000) Quantification of neurosteroids in rat plasma and brain following swim stress and allopregnanolone administration using negative chemical ionization gas chromatography/mass spectrometry. Anal Biochem 287:153–166

    Article  PubMed  CAS  Google Scholar 

  • Wieland S, Lan NC, Mirasedeghi S, Gee KW (1991) Anxiolytic activity of the progesterone metabolite 5 alpha-pregnan-3 alpha-o1-20-one. Brain Res 565:263–268

    Article  PubMed  CAS  Google Scholar 

  • Wolkowitz OM, Epel ES, Reus VI (2001) Stress hormone-related psychopathology: pathophysiological and treatment implications. World J Biol Psychiatry 2:115–143

    Article  PubMed  CAS  Google Scholar 

  • Wolkowitz OM, Reus VI, Keebler A, Nelson N, Friedland M, Brizendine L, Roberts E (1999) Double-blind treatment of major depression with dehydroepiandrosterone. Am J Psychiatry 156:646–649

    PubMed  CAS  Google Scholar 

  • Wu FS, Gibbs TT, Farb DH (1991) Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-d-aspartate receptor. Mol Pharmacol 40:333–336

    PubMed  CAS  Google Scholar 

  • Zhao ZY, Xie Y, Fu YR, Li YY, Bogdan A, Touitou Y (2003) Circadian rhythm characteristics of serum cortisol and dehydroepiandrosterone sulfate in healthy Chinese men aged 30 to 60 years. A cross-sectional study. Steroids 68:133–138

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

Support for this research was provided by the following sources: K23 MH 65080 (CEM), T32 MH70448 (WTT; PI Dan G. Blazer, M.D. Ph.D.), MIRECC VISN 6 (PI Gregory McCarthy, Ph.D.), Durham VA REAP (PI Roger Madison, Ph.D.), and a grant from Phillip Morris USA (JER). We thank Gillian J. Parke for her excellent assistance in the preparation of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christine E. Marx.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marx, C.E., Trost, W.T., Shampine, L. et al. Neuroactive steroids, negative affect, and nicotine dependence severity in male smokers. Psychopharmacology 186, 462–472 (2006). https://doi.org/10.1007/s00213-005-0226-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-005-0226-x

Keywords

Navigation